Eckert & Ziegler AG (EUZ.F,EUZ.DE), a German isotope technology components firm, said on Wednesday that it has agreed to supply Actinium-225, or Ac-225, to SK Biopharmaceuticals Co., Ltd.(326030.KS), a South Korean drug maker.
The supply of Actinium-225 will boost SK Biopharmaceuticals' research and development activities in radiopharmaceutical therapies.
SK Biopharmaceuticals' development pipeline includes SKL35501, a radiopharmaceutical labeled with Ac-225 with potential in the treatment of multiple types of cancer, including colorectal, breast, pancreatic, and others.
The German company is a supplier of Gallium-68, Lutetium-177, Yttrium-90, and Actinium-225 in GMP quality to pharmaceutical companies and research institutions.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.